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1. Introduction 
With the implementation of newborn hearing screening programs, permanent congenital 
hearing loss is typically diagnosed in babies within six weeks of age (JCIH, 2007). Many 
hearing screening programs use a two-stage transient-evoked otoacoustic emissions 
(TEOAEs) screen because of the ease-of-use and time- and cost-effectiveness (Hayes, 2003). 
Because infants are unable to provide reliable behavioural responses to sound stimuli, 
hearing thresholds are estimated using the auditory brainstem response (ABR), a measure of 
synchronous neural activity that correlates well with behavioural thresholds in infants with 
normal hearing and conductive and sensorineural hearing loss (Hyde et al., 1990). As a 
result, early intervention is targeted, resulting in spoken language development that is 
similar to normally hearing peers and significantly better than later identified peers, 
irrespective of the magnitude of loss (Yoshinaga-Itano et al., 1998).  
On the other hand, Auditory Neuropathy Spectrum Disorder (ANSD) describes a unique 
type of permanent hearing loss that is not identified with newborn hearing screening 
programs that utilise otoacoustic emissions (OAEs) as a first-line screen, unless the 
impairment is detected through alternative risk-based screening programs (which occurs for 
individuals with additional and/or associated neonatal problems such as anoxia and 
hyperbilirubinemia; Rance et al., 2002). ANSD is characterised by significantly disordered 
auditory afferent neural conduction with preservation of cochlear outer hair cell function 
(Starr et al., 1996), based on clinical findings of normal OAEs and/or cochlear microphonic 
(CM) potentials with the absence or marked abnormality of the ABR. Despite poor afferent 
responses, individuals with ANSD have pure tone thresholds that may vary from normal to 
profound hearing loss in a variety of audiometric configurations (Starr et al., 2000). 
Therefore OAE screening would inaccurately “pass” these individuals and, while ABR 
screening would detect them, diagnostic ABR testing would not provide an accurate 
estimate of hearing thresholds.  
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The estimation of hearing thresholds in infancy is only one of the challenges that are faced in 
selecting the most appropriate intervention pathways and hearing devices for these 
individuals. Unlike standard sensorineural hearing losses which show impaired spectral 
processing, largely resulting from the loss of outer hair cells (OHCs), individuals with 
ANSD show distinct deficits in auditory temporal processing. Presumably, this results from 
the disordered or temporally jittered neural activity. This is the ability of the auditory 
system to detect and analyze temporal cues within an acoustic signal that occur within 
milliseconds (Green, 1971). Auditory temporal processing plays an important role in the 
development of speech perception, language and reading skills in all children and it has 
been speculated that this underpins most auditory processing capabilities (Benasich & Tallal, 
2002; Musiek, 2003). Both fast (20-40Hz) and slow (<2-16Hz) temporal processing is needed 
to: (i) detect and resolve relevant phonetic sounds and the speech envelope within 
segregated speech; and (ii) extract speech sounds from noisy environments, where it is the 
perception of the sound onset that is most critical to detect speech-in-noise (Drullman et al. 
1994a,b; Kaplan-Neeman et al., 2006; Shannon et al., 1995). Rapid temporal processing 
abilities are important for the development of phonological awareness (Nittrouer, 1999), 
which is significantly correlated with language and reading ability in children (Stark & 
Tallal, 1979; Benasich & Tallal, 2002; Catts et al., 2002), although not exclusively related 
(Bretherton & Holmes, 2003). In particular, this is highlighted in many cases of dyslexia and 
specific language impairment (SLI) which show impaired temporal processing abilities 
compared with children with normal language and reading development (Farmer & Klein, 
1995). However the temporal processing deficits in individuals with dyslexia and SLI appear 
less severe in comparison with most individuals with ANSD (see Figure 1).  
2. Temporal processing & speech perception 
Psychoacoustic measures in adults and children with ANSD show impairments of pitch 
discrimination (particularly at lower frequencies), temporal integration, gap detection, 
temporal modulation detection, backward and forward masking, perception of speech-in-
noise and sound localization using inter-aural time differences (Rance et al., 2004; Starr et al., 
1996; Zeng et al., 1999; Zeng et al., 2005). It is assumed that these deficits are caused by the 
disrupted temporal perception. Several studies have demonstrated that the magnitude of 
the disruption of temporal processing in individuals with ANSD varies considerably and it 
is this which determines speech perception outcomes, rather than hearing thresholds per se 
(Rance et al., 2004; Zeng et al., 1999, 2005; Kumar & Jayaram, 2005). Using amplitude 
modulated-broadband noise with varying modulation depths at three frequencies (10, 50 
and 150 Hz), Rance and colleagues (2004) compared differences in temporal processing 
abilities between three populations of children; normal hearing (n=10), ANSD (n=14) and 
sensorineural hearing loss (n=10) and compared this with speech perception outcomes using 
Consonant-Nucleus-Consonant (CNC) words. The latter two groups with hearing loss 
showed pure tone thresholds within a mild-moderate range.  While no difference existed in 
temporal processing abilities for individuals with normal hearing and sensorineural hearing 
loss, significant differences existed between these populations and children with ANSD. 
When the ANSD population was stratified into good (≥30% phoneme recognition; n=7) and 
poor performers (<30% phoneme recognition; n=7), the disruption was only mild for those 
with good speech perception scores, and disruptions to low frequency modulations (10 Hz) 
only occurred in those with very poor speech discrimination. Similar outcomes have been 
demonstrated by Zeng et al. (2005) who examined temporal modulation detection as a  
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Fig. 1. Thresholds of gap detection for adults with ANSD (black circles; from Michalewski et 
al., 2005) and children with dyslexia (grey circles; from Van Ingelghem et al., 2001) 
compared to adults and children (120–144 months) without ANSD or dyslexia (dashed line). 
function of modulation frequency (ranging from 2–2000 Hz) in 16 ANSD adult participants, 
with hearing thresholds varying from normal to severe. Additionally, Kumar and Jayaram 
(2005) evaluated temporal modulation detection abilities at six modulation frequencies, (4, 
16, 32, 64, 128 and 200 Hz), in 14 adult ANSD participants and compared the results with 30 
normally hearing participants, matched by age and gender. Results were stratified by  
speech perception abilities and demonstrated that ANSD participants who had speech 
perception scores of greater than 50% showed greater sensitivity to the temporal 
modulations when compared to those who had speech perception scores of less than 20%. 
While the results from Rance et al. (2004) indicate that those individuals with good speech 
perception scores show good temporal processing at low-frequency rates of modulation (10 
Hz), Kumar and Jayaram’s (2005) study showed poor temporal processing at all frequencies 
for adults with good (>50%) and poor (>20%) speech perception scores using open-set 
Kannada words. Nonetheless, if averaged, temporal resolution scores for all ANSD 
participants seemed to be similar at 10 Hz for all three studies discussed above, of an 
approximate -10 dB detection threshold. In contrast to temporal modulation detection, gap 
detection thresholds (psychoacoustic measure of temporal resolution) are consistently 
impaired in individuals with ANSD. While normal-hearing listeners require 2–3 ms at 
supra-threshold levels (40–50 dB SPL) to detect a brief gap in noise, ANSD individuals 
require 20–28 ms (Starr et al., 1996; Zeng et al., 1999; Zeng et al., 2005).  
In any case, for individuals with ANSD, it seems that it is the temporal processing ability 
that is paramount to the development of speech and language and, therefore, the success of 
hearing aid fitting, rather than pure tone thresholds per se. While objective measures of 
temporal processing are beginning to emerge in the literature, these are clearly needed to 
guide timely decisions about device fitting, particularly in view of the critical period of 
language development. 
Participants 
ANSD Dyslexics 
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3. Cochlear implantation and site-of-lesion 
It is clear that early detection of hearing loss minimises the longer-term consequences of 
auditory deprivation on speech perception, language and socio-emotional development 
(Geers, 2006; Moog & Geers 2010; Moog, Geers Gustus & Brenner, 2011). For individuals 
with severe to profound sensorineural hearing loss, cochlear implantation is commonly part 
of an effective intervention program, providing greater access to speech than conventional 
hearing aids. Earlier implantation as well as early educational placement and / or intensive 
habilitation facilitates more rapid and extensive language development as well as improved 
speech perception and production (Hayes et al., 2009; Nicholas & Geers, 2007; Svirsky et al., 
2004; Tomblin, et al., 2005). Animal models of sound deprivation highlight the extent of 
anatomical changes that can occur within the auditory pathways and cortex with congenital 
hearing loss (Fallon et al., 2008). However, the effects of early implantation appear to 
facilitate normal synaptic and cortical development through restored sound input (Kral et 
al., 2001, 2002; O’Neill et al., 2010; Ryugo et al., 2005). Kral and Eggermont (2007) suggest 
that the sensitive period for language learning in children with pre-lingual hearing loss 
fitted with a cochlear implant correlates with the age of significant reduction in synaptic 
density in normally hearing subjects (4-5 years of age). This is consistent with 
electrophysiological data from Sharma and colleagues (2002a&b; 2005, 2009) who show that 
later implanted children (over 7 years of age) show significant and sustained delays in the 
latency of the P1 peak of the cortical auditory evoked potential (CAEP). On the other hand, 
delays in the P1 peak of earlier implanted children (under 3.5 years of age) are resolved 
within 6-8 months after implant surgery. It is assumed, therefore, that the comparatively 
better functional outcomes from earlier implantation partly result from greater synaptic 
development and maturity occurring within the critical period (Hammes et al., 2002; 
Harrison et al., 2005). While early identification and intervention are also important for 
children with ANSD, identifying who will benefit from cochlear implants and deciding when 
to implant is more challenging than for individuals with sensorineural hearing loss.  
The term “auditory neuropathy” was initially used to describe this disorder, consistent with 
the findings from a longitudinal study of 10 individuals, 8 of which later developed 
concomitant peripheral neuropathies (Starr et al., 1996). In this case, it was assumed that the 
lesion existed at the auditory nerve resulting from demyelination of peripheral neurons. 
However, subsequent studies have shown that proportionally large numbers of individuals 
diagnosed with ANSD do not develop additional neuropathies and good functional 
outcomes have been reported in many cases after cochlear implantation (Mason et al., 2003; 
Gibson & Sanli, 2007; Shannon et al., 2001), which suggest that the lesion is pre-neural. 
Therefore the term has been widely contested because of the potentially negative impact this 
might hold for clinical decision-making, such as cochlear implantation (that is, this may be 
considered a deterrent for implantation). While other terms including auditory dys-
synchrony (Berlin et al., 2001) were suggested as alternatives, the physiological mechanisms 
underpinning this disorder are unclear and are likely to be many. Certainly genetic, 
electrophysiological and imaging data show that multiple sites of lesion can exist (Cacace & 
Pinheiro, 2011; Manchaiah et al., 2010; Santarelli, 2010; Varga et al., 2003) and this is 
supported by the variability in objective measurements, such as electrically-evoked ABR 
(EABR), after cochlear implantation (McMahon et al., 2008; Shallop et al., 2001). To 
encompass the breadth of different lesions (whether synaptic, neural or brainstem) that 
could lead to the clinical classification of this disorder and the wide range of functional 
outcomes, an alternative term “auditory neuropathy spectrum disorder”, or ANSD, was 
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proposed at the International Conference of Newborn Hearing Screening (Como, 2008), 
although this term also has little prognostic information about functional outcomes within 
this population. Broadening the term may also lead to greater inclusion of identifiable 
lesions of the auditory nerve, such as cochlear nerve deficiency (CND; Buchman et al., 2006), 
or hereditary conditions of known late-onset auditory neural demyelination, such as 
Freidreich’s Ataxia (Rance et al., 2008) and Charcot-Marie Tooth disease, which will 
certainly have poorer outcomes with cochlear implantation (Madden et al., 2002; Song et al 
2010) than the population of ANSD without known neural lesions. 
Various studies have shown that the prevalence of this disorder ranges from 0.23-24% in the 
at-risk neonatal population (Rance et al., 1999; Berg et al., 2005) to 5.1-15% of children with 
sensorineural hearing loss (Madden et al., 2002b; McFadden et al., 2002). While many cases 
of ANSD occur with infectious diseases, perinatal and postnatal insults and genetic 
disruptions (Madden et al., 2002), some have no co-morbid medical problems or familial 
hearing loss. Common medical insults assumed to cause ANSD include 
hyperbilirubinaemia (which may account for up to 48.8% of cases; Berlin et al., 2010) and/or 
perinatal anoxia, prematurity and low birth-weight (Berlin et al., 2010; Beutner, et al., 2007; 
Salujaet al., 2010). Each of these can have widespread effects on the auditory system as well 
as other neurodevelopment consequences, including cerebral palsy and cognitive or 
neurodevelopmental delay (Johnson & Bhutani, 2011; Schlapbach et al., 2011). Additionally, 
some infants diagnosed with ANSD within this high-risk category show full or partial 
recovery of ABR waveforms within 12 months of diagnosis or following medical 
intervention (such as exchange transfusion), which indicates that some cases of ANSD may 
be due to neuromaturational delay or reversible transient brainstem encephalopathy (Amin 
et al., 1991; Krumholz et al., 1985; Granziani et al., 1967). While ANSD can be detected early 
through newborn hearing screening programs or through targeted screening of the “at-risk” 
populations in the NICU, no uniform management plan exists because of the variability in 
hearing thresholds, temporal processing abilities and sites-of-lesion that cannot be measured 
using behavioural tests at that age. Early intervention and fitting of hearing aids, 
particularly high-powered aids, or cochlear implants is considered, with caution, to avoid 
permanently damaging normally functioning outer hair cells and neural structures, that 
may be immature rather than permanently disordered (Maddon et al., 2002a,b). As many 
individuals with ANSD show hearing thresholds within a normal to moderate range (Starr 
et al., 2000; Berlin et al., 2010), it is clear that neural information is being transmitted to the 
auditory cortex. However, the sound quality of the auditory input is variable amongst this 
population, with speech discrimination scores disproportionate to the pure tone audiogram 
(Rance et al., 2002), and often significantly poorer in noisy environments (Starr et al., 1996). 
Hyperbilirubinaemia describes the high concentrations of unconjugated bilirubin that can 
occur in the newborn, which is a neurotoxin that can cause irreversible neurological 
damage, including auditory, motor and ocular movement impairments (Shapiro & Popelka, 
2011). The Gunn rat pup provides a model of the effects of kernicterus in the neonate. 
Electrophysiological and anatomical studies have shown that severe cases of kernicterus in 
the Gunn rat lead to disruption of the auditory pathway from the cochlear nucleus to the 
higher auditory brainstem, including the inferior colliculus (Uziel et al., 1983). While both 
inner and outer hair cells appear to be spared by high levels of bilirubin, the spiral ganglion 
cells of auditory neurones can be disrupted (Shapiro, 2005), indicating a neuronal cause of 
ANSD. Improvements in auditory brainstem responses in infants with hyperbilirubinemia, 
particularly after exchange transfusions, have been noted by a number of authors (Deliac et 
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al., 1990; Perlman et al., 1983; Rhee et al., 1999; Roberts et al., 1982). Rhee and colleagues 
(1999) evaluated TEOAEs and ABR responses in 11 neonates after exchange transfusions for 
hyperbilirubinemia. All infants showed normal OAE responses but 3 showed absent ABR 
responses to clicks at stimulus levels of 90dBnHL and, within 12 months of follow-up 1 
showed significant improvements in hearing thresholds, estimated using ABR.  
Prematurity is identified as another major cause of ANSD. However, it is likely that it is not 
the prematurity per se that underpins the damage to the auditory system but associated 
conditions of low-birth weight, hypoxia from respiratory failure, hyperbilirubinemia, 
presence of fetal pathology (infection or retarded intrauterine growth) or perinatal 
pathology, or ototoxicity from antibiotics given for hyaline membrane disease (Ferber-Viart 
et al., 1996). Extremely low birth-weight infants are at risk of developing ANSD (Xoinis et 
al., 2007). A retrospective study by Xoinis and colleagues (2007) showed that the prevalence 
of ANSD was 5.6/1000 in the NICU (n=24) compared with 16.7/1000 infants with 
sensorineural hearing loss (n=71). They identified that infants with ANSD were born more 
prematurely (mean gestational age 28.3±4.8 weeks compared with 32.9±5.2 weeks of SNHL 
infants) and showed significantly lower birth weights (mean 1.318±0.89 kg compared with 
1.968±1.00 kg of those with SNHL). Psarommatis and colleagues (2006) retrospectively 
reviewed medical records of 1150 NICU neonates and identified 25 infants with ANSD. Of 
these, 20 were re-examined at approximately 5 months of age and 12 showed full recovery 
of the ABR with 1 infant showing partial recovery (with click ABR thresholds measured to 
50dBnHL). A significant difference in mean birth-weight and gestational age (GA) was 
found between infants who recovered (BW= 1.89±0.90 kg and GA= 32.9±1.1 weeks) and 
those who showed no recovery (BW= 3.0±0.66 kg and GA= 36.4±1.25 weeks), suggesting 
that those born more prematurely and with lower birth weight may be more at risk of 
delayed neuromaturational development rather than ANSD. Amatuzzi and colleagues 
(2001) evaluated the temporal bones of 15 non-surviving NICU infants, 12 who failed the 
ABR screen bilaterally and 2 who passed bilaterally. Of those who failed, 3 infants (all born 
prematurely) showed bilateral selective inner hair cell loss whereas both infants who passed 
the ABR screen showed no cochlear histopathologic abnormalities. This may suggest that 
pathologies related to prematurity are more likely to target inner hair cells than neural 
elements, making these individuals good candidates for cochlear implantation. 
Two large-scale studies of individuals with ANSD both conducted in 2010 by Teagle et al. 
(n=140) and Berlin et al. (n=260) have provided the most comprehensive information to date 
about the etiologies of ANSD and outcomes of individuals fitted with hearing aids and / or 
cochlear implants. Berlin and colleagues reported that only 11 of 94 individuals who used 
hearing aids showed good speech and language development. 60% of the 258 subjects 
reported had pure tone thresholds characterised as being between normal to moderate-severe 
(within a very aidable range) and the remaining 40% had thresholds described as either 
moderate-profound, severe, severe-profound or profound, presumably fitting within the more 
typical range of CI candidacy. On the other hand, 85% of those fitted with a CI showed 
successful outcomes (evaluated by parent and teacher report) and 8% were too young to 
conclude this. Teagle and colleagues reported that of the 52 individuals with ANSD who were 
implanted, 50% demonstrated open-set speech perception abilities, although 30% were not 
tested because of their young actual or developmental age and individuals identified with 
CND showed 0% open-set speech perception scores. Therefore it is clear that ANSD is 
heterogeneous in cochlear implantation outcomes, possibly partly related to the high incidence 
of co-morbidity and multiple disabilities as well as differences in the site-of-lesion. 
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4. Role of evoked potentials in decision-making 
Given the variability in the magnitude of temporal processing disruption and in the sites-of-
lesion in ANSD, which is important for CI outcomes, the focus of our research has been in 
the development and/or evaluation of objective measures to better quantify temporal 
processing ability (Al-meqbel & McMahon, 2011) and identify the site-of-lesion (McMahon 
et al., 2008) in ANSD. Cortical auditory evoked potentials (CAEPs) have been shown to be 
important in the measurement of temporal processing ability because they are less reliant on 
rapid neural timing than the auditory brainstem responses. Rance and colleagues (2002) 
were the first to show that the presence of CAEPs in ANSD with a mild to moderate hearing 
loss correlated well with good aided speech perception outcomes. In this study, 8 of 15 
children showed good aided functional outcomes, identified as >30% correctly identified 
phoneme scores using Phonetically-Balanced Kindergarten Words, and each of these 
showed present CAEP waveforms to either a pure tone (440Hz for 200ms) and/or a 
synthesised speech token (/daed/) presented at a comfortable level using headphones or 
insert earphones.  The remaining 7 children who showed poor aided speech perception 
results also showed absent CAEP waveforms to either the pure-tone or speech stimuli. This 
important finding highlighted the role of evoked potentials in guiding management 
decisions in this population. Michalewski and colleagues (2005) used CAEPs measured with 
an active and passive gap-in-noise paradigm to determine temporal processing acuity in 14 
adults with ANSD. They obtained CAEP responses from 11 subjects, with active responses 
measured in all 11 subjects but passive responses in only 7 subjects. No response was 
measured for 3 individuals who showed profound hearing loss. In 7 subjects who showed 
present passive responses to gap detection, good correlations were found between 
psychoacoustic and objective CAEP measures of gap detection. In 3 of 4 subjects with only 
active responses, a good correlation was also found. This unexpected appearance of the 
CAEP in response to attention may shed some light into the role of attention in the 
synchronisation of responses in some individuals with ANSD. 
Subsequently, our retrospective study (McMahon et al., 2008) showed that the frequency-
specific electrocochleographic waveforms, measured from the round-window of 14 
implanted children with ANSD with severe-profound hearing loss, correlated well with the 
EABR measured immediately after implantation. This supports the use of frequency-specific 
electrocochleography (ECochG) in enabling better delineation of site-of-lesion. 
Electrocochleography is a useful tool in the identification of cochlear lesions because it 
enables more accurate recording of the summed extracellular currents from cochlear hair 
cells (the cochlear microphonic, CM; Figure 2A in the guinea-pig and Figure 2E in the 
human, and summating potential, SP; Figure 2B in the guinea-pig and Figure 2G in the 
human), the excitatory post-synaptic currents (known as the dendritic potential, DP) arising 
from the primary afferent dendrites, the terminal endings of the primary afferent neurones 
that synapse with the inner hair cells (Figure 2C), and the compound action potential (CAP) 
from the primary afferent neurones which is described by three dominant peaks, labelled 
N1, P1 and N2 (Figure 2D; see Sellick et al., 2003 for a review). Because there is a cascade of 
events that leads to the generation of an action potential (see Fuchs, 2005 for a review), the 
presence or absence of these potentials can indicate where a lesion is located. That is, 
depolarisation of inner hair cells leads to the opening of L-type calcium channels in the 
basolateral wall of these cells and, ultimately, the mobilisation and release of 
neurotransmitter from the base of these cells. This process involving the gene otoferlin that 
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is implicated in some types of ANSD (Roux et al., 2006). Neurotransmitter diffuses across 
the synaptic cleft and binds to the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPA) channels on the dendrite which allows an influx of positive ions, 
generating an excitatory post-synaptic potential (EPSP) inside  
 
Fig. 2. Using a round-window electrode, local hair cell, dendritic and neural potentials can 
be measured using frequency-specific electrocochleography in the anaesthestised guinea pig 
(A-D) or human (E-F). A single polarity low-frequency tone-burst clearly shows the cochlear 
microphonic (CM) waveform (A&E). A high-frequency alternating polarity tone-burst is 
used to elicit the summating potential (SP; B&F), dendritic potential (DP; C) and compound 
action potential (CAP; D). The presence of the CAP obscures the DP, which is only observed 
in pathological cases such as ANSD in human. Note that the differences observed between 
the guinea-pig and human CM and SP are largely because of the different stimulus-
frequencies and time-scales used to elicit and display the response. 
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the dendrite. If this voltage is large enough, it will trigger an action potential, which is often 
considered an all-or-none event. Selective disruption of these potentials using 
pharmacological block in an anaesthetised guinea-pig model demonstrates this point 
(Figure 2A-D). Intracochlear perfusion of the excitotoxic drug kainite which blocks the 
ligand-gated AMPA channels, abolishes both the CAP and the DP, whereas the SP 
amplitude is unchanged (Figure 2B). On the other hand, intracochlear perfusion of 
tetrodotoxin (TTX), a spider venom which blocks the voltage-gated Na+ channels, abolishes 
the CAP, but the SP remains and the DP can be observed in the average waveform (Figure 
2C which previously was masked by the much larger CAP observed in the normal hearing 
guinea-pig (Figure 2D).  
There are two main limitations to this technique. Firstly, the currents measured from the 
recording electrode are local currents (i.e. those generated within the proximity of the 
recording electrode) and, in our study, were measured from the cochlear round window. 
Therefore, to a first approximation, we assumed that any disruption identified at the round 
window (which has a best frequency of about 8kHz in humans) was the same throughout 
the cochlea. Secondly, a disruption at a particular site along the auditory pathway might be 
one of multiple disruptions that could occur. As previously discussed, many of the 
underlying causes of ANSD cause widespread disruption that may impact cochlear and 
brainstem structures and are not highly localised to a single site. In any case, in the study 
conducted by McMahon et al. (2008), we identified two types of ECochG waveforms in 14 
individuals with ANSD, each who showed normal Magnetic Resonance Imaging (MRI) 
recordings (with no identifiable neural abnormalities): (i) a delayed latency SP that 
showed little or no compound action potential, suggestive of a pre-synaptic or synaptic 
lesion, and (ii) a normal latency SP with a clear DP waveform that was more visible at 
lower sound levels (where it was assumed that the much larger SP distorted the DP 
waveform at higher sound levels), suggestive of a neural or post-synaptic lesion (see 
Figure 3). In 6 of 7 ears implanted with the pre-synaptic or synaptic ECochG waveform, 
normal morphology EABR waveforms were measured from electrical stimulation of the 
majority of the 22 electrodes of the cochlear implant. Additionally, in 6 of 6 ears 
implanted with post-synaptic ECochG waveforms, the EABR waveforms were grossly 
abnormal or absent for all 22 electrodes (see Figure 3). 
The physiological mechanisms underlying spike failure in cases of ANSD and leading to a 
pre-synaptic  or synaptic mechanism of disruption could be numerous. Assuming a normal 
distribution of EPSP amplitudes results from the quantal release of neurotransmitter (Fuchs, 
2005), then a reduction in the amplitude (or number) of EPSPs would reduce the probability 
of spike initiation (see Figure 4A). This might occur due to disruption of transmitter-release 
(possibly mediated by otoferlin deficiency, Roux et al., 2006) or a scattered loss of IHCs 
(Amatuzzi et al., 2001). Alternatively, an increase in the trigger-level voltage could reduce 
the probability of EPSPs reaching this critical voltage (see Figure 4B), or, depolarisation of 
the dendrite itself (possibly from lateral efferent modulation; Brown, 1987) would also 
reduce the chance of EPSPs generating spikes (see Figure 4C). 
Santarelli and colleagues (2008) also measured ECochG waveforms in 8 children and adults 
with ANSD, using a forward masking paradigm of rapidly presented click stimuli to 
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differentiate between cochlear and neural sites-of-lesion. Given that neural potentials decay 
significantly with faster rates of stimulation due to neural refractoriness (Miller et al., 2001), 
the amount of adaption in the measured response enables differential diagnosis of the site-
of-lesion. In this study, 3 patterns were identified: (i) presence of the SP without a CAP, 
consistent with a pre-synaptic lesion; (ii) presence of the SP and CAP, consistent with a post-
synaptic lesion and (iii) significantly prolonged latency potentials (up to 12 ms), which the 
authors suggest may result from slowed neural conduction and/or reduced action potential 
generation. Since implantation in cases of cochlear nerve deficiency is known to have poorer 
outcomes (Buchman et al., 2006), then ECochG provides a useful tool in the differential 
diagnosis of ANSD.  
 
Fig. 3. Electrocochleographic recordings using an 8kHz alternating time-burst show two 
types of waveforms exist in the 14 ANSD individuals in this study: (A) a delayed SP with 
either a small or absent CAP present, consistent with normal implanted EABR waveforms 
suggesting a pre-synaptic lesion and (B) a normal latency SP with a DP present at lower 
sound levels, consistent with absent or grossly abnormal implanted EABR responses, 
consistent with a post-synaptic lesion.  
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Fig. 4. Physiological mechanisms of spike failure from pre-synaptic or synaptic disruptions 
might include: (A) a reduction in the amplitude of the EPSPs; (B) an increase in the voltage 
need to reach trigger-level; or (C) hyperpolarisation of the membrane potential of the 
primary afferent dendrites (possibly from lateral efferent modulation). 
Our next study aimed to identify whether EABR provided a good measure of functional 
performance in implanted individuals with ANSD and severe-profound hearing loss. In this 
study (Bate & McMahon, in preparation), we compared speech perception outcomes using 
the phoneme scores of age-appropriate word lists (either CNC words or Manchester Junior 
Words) presented at 65dBSPL in the free-field with a speaker located at 0 degrees azimuth 
with electrically-evoked CAEP (ECAEP) waveforms measured at least 1 year after 
implantation and EABR waveforms measured immediately after implantation. Ten 
individuals with ANSD diagnosed by present CM but absent ABR waveforms and with 
normal MRI participated in this study and each showed good speech perception (scoring 
>50% phonemes correct) and normal motor and cognitive development. Interestingly, only 
40% of these individuals showed good EABR waveform morphology but 80% showed good 
ECAEP waveforms when elicited by direct electrical stimulation at a comfortably loud level 
from at least 2 of 3 spatially separated electrodes (representing an apical, mid- and basal 
position of the electrode array). This suggests that even in cases where cochlear 
implantation may not by-pass the lesion underpinning ANSD, it may provide the necessary 
amplification needed for the individual to access the speech signal. We did not perform 
further complex speech, language or reading testing to determine age equivalence, however, 
we suspect that differences between individuals with present EABR and absent EABR may 
exist if we evaluated the broader population base and if our testing was more extensive. 
Nonetheless, these results do suggest that cochlear implantation can benefit some 
individuals with a post-synaptic site-of-lesion. It is important to highlight that both studies 
we have conducted included only those individuals with normal MRI scans, indicating no 
structural abnormality of the auditory nerve (although it is acknowledged that even high 
resolution MRI cannot identify all structural abnormalities). Previous studies have shown 
that individuals with a known lesion on the auditory nerve (which would also be defined as 
a post-synaptic or neural lesion) including neural demyelination (Miyamoto et al., 1999) and 
auditory nerve agenesis or hypoplasia (Maxwell et al., 1999; Gray et al., 1998; Buchman et al 
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2006) have significantly poorer outcomes following cochlear implantation. While some 
authors strongly pursue the differentiation of terminology for a true neuropathy of the 
auditory nerve and an endocochlear disruption that produces the same clinical results 
(Loundon et al., 2005), the more inclusive term of ANSD seems to be generally used within 
the literature. We agree that such a differentiation is important to better understand the 
mechanisms that underpin this disorder and to develop targeted intervention strategies.  
Figure 5 shows three case studies that highlight the variability in evoked potentials and 
functional outcomes that occur in cases of ANSD, either with normal or abnormal MRI. Case 
1 illustrates the electrophysiological test battery as being a good predictor of a good 
outcome after cochlear implantation in the first ear implanted (4.5 years of age), but not in 
the second (10 years of age). The electrophysiological test result pre-implantation measured 
by ECochG and trans-tympanic EABR indicate a pre-synaptic site of lesion (as described by 
McMahon et al., 2008). Specifically, as shown in Figure 5A, the ECochG results of a delayed 
latency SP and no evidence of a DP in both ears are consistent with a pre-synaptic lesion 
(McMahon et al., 2008). The preoperative test results, coupled with the evidence of normal 
anatomy as shown on preoperative imaging allow prediction of a good outcome.  
Electrophysiology post-cochlear implant insertion was measured using an intraoperative 
EABR which showed good responses from all channels in the left and right (data not shown) 
ears. No other disabilities are noted with this individual and as predicted an open set speech 
perception ability as measured by was achieved at 6 months post cochlear implantation. 
These results are consistent with those seen in other studies such as Gibson and Sanli (2007) 
who showed 32/39 children with good EABR results and good functional outcomes. It is 
possible that the poorer functional outcomes measured in the subsequently implanted ear 
arose from the prolonged delay in implanting the second ear (Ramsden et al., 2005; Gordon et 
al., 2008) although conflicting evidence exists about the impact of duration of sequential 
implantation on functional outcomes (Zeitler et al., 2008). In any case, in contrast to Case 1, 
Case 2 provides an example of a subset of individuals identified as having ANSD with 
additional confounding factors, including cerebral palsy, developmental delay, Autism 
Spectrum Disorder. While the electrophysiological test results may be similar in both cases, it 
is presumed that the addition of significant other factors, including cognitive or 
developmental impairment, may be the cause of the poorer functional outcomes. Poor 
morphology or the absence of wave V on an EABR post cochlear implantation has been shown 
to be associated with poor speech perception outcomes (Rance, 1999; Gibson & Sanli, 2007; 
Song et al., 2010). Case 3, shows ECochG results with a present SP and SP and very poor 
morphology EABR, consistent with a post-synaptic site-of-lesion (McMahon et al., 2008). 
Despite this, functional assessment shows a good Manchester Words Junior phoneme score 4 
years after implantation. Given the results of these studies, we present an evoked-potential 
protocol that might be utilised to better inform device and management decisions in 
individuals with ANSD (see Figure 6). It is not intended that this protocol be used alone. 
Intensive monitoring of auditory behaviours and receptive and expressive language 
development is important in providing complementary information to determine the most 
appropriate way to manage a child with ANSD. On the other hand, this protocol intends to 
support the decision-making process by providing information about the individual’s 
temporal processing ability, needed to develop speech and language, and the location of the 
lesion, which might influence cochlear implantation outcomes. Roush (2008) highlights the 
types of speech perception and behavioural questionnaires that are useful in obtaining 
behaviourally relevant information in this population. 
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Fig. 5. Electrocochleography and EABR testing provides information useful in 
understanding the likely site of lesion in ANSD (McMahon et al., 2008; Gibson & Sanli, 
2007). These specific cases have been used to demonstrate the variability of outcomes in 
this population. Case 1: a child with normal neonatal medical history who was bilaterally 
sequentially implanted, and electrocochleography and EABR results on both sides (EABR 
RE not shown) are consistent with a pre-synaptic lesion. The right ear was fitted at 4.5 
years and the left at 10 years of age. Good functional outcomes were measured using CNC 
words in quiet with the right ear alone but poor functional outcomes were measured in 
the left. Case 2: a child with a significant medical history but with normal VIIIth nerve. 
ECochG waveforms show a normal latency SP but no evidence of a DP, suggestive of a 
pre-synaptic lesion. EABR waveforms are good for basal electrodes but poorer for apical 
electrodes. Poor functional outcomes were reported and no functional assessments were 
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able to be performed. Case 3: a child born with no medical history of complications. 
ECochG waveforms showed the presence of the SP and DP, suggestive of a post-synaptic 
lesion. EABR results showed poor morphology waveforms for all channels. Despite this, 
good functional outcomes were measured using Manchester Junior Words. 
 
 
 
Fig. 6. A possible protocol for the use of evoked potentials in directing management of 
ANSD. It is important to note that evoked potentials should not be used in isolation of 
behavioural testing and observations. 
In conclusion, while the variability of ANSD presents a challenge to audiological 
management, a structured approach using parental questionnaires to evaluate auditory 
behaviours as well as objective testing may assist in guiding effective decision-making in 
this population in infancy. 
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